Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Devanand M Pinto

Showing results (41-50 of 43) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 43 results.
Cell Metabolism|December 8, 2021
Coenzyme A fuels T cell anti-tumor immunityMichael St Paul, Samuel D Saibil, SeongJun Han, et al.
Immunity|February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunityKebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Molecular Therapy. Oncology|April 10, 2024
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, et al.
Pageof 5

Showing results (41-50 of 43) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 43 results.
Cell Metabolism|December 8, 2021
Coenzyme A fuels T cell anti-tumor immunityMichael St Paul, Samuel D Saibil, SeongJun Han, et al.
Immunity|February 9, 2022
Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunityKebria Hezaveh, Rahul S Shinde, Andreas Klötgen, et al.
Molecular Therapy. Oncology|April 10, 2024
Discovery and preclinical development of a therapeutically active nanobody-based chimeric antigen receptor targeting human CD22Scott McComb, Mehdi Arbabi-Ghahroudi, Kevin A Hay, et al.
Pageof 5